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Abstract .  Cell-mediated immunity plays an important but incompletely understood role in host defense 
against Cryptococcus neoformans. Because of their multiple capacities as cytokine-secreting cells, cyto- 
toxic cells, and antigen-specific suppressor cells, CD8 positive T lymphocytes could potentially either 
enhance or impair host defense against C. neoformans. To determine whether CD8 T cells enhance or 
inhibit host defence during an infection with a highly virulent strain of C. neoformans, we examined 
the effect of in vivo CD8 cell depletion on suNival and on the number of organisms in mice infected 
by either the intratracheal or intravenous routes. Adequacy of depletion was confirmed both phenotyp- 
ically and functionally. Regardless of the route of infection, we found that survival of mice depleted of 
CD8 T cells was significantly reduced compared to undepleted mice. Surprisingly, however, CD8 
depletion did not alter organism burden measured by quantitative CFU assay in mice infected by either 
route. These data demonstrate that CD8 positive T cells participate in the immune response to a highly 
virulent strain of C. neoformans. By contrast to minimally virulent isolates that do not cause a life 
threatening infection, the immune response to a highly virulent isolate does not alter the burden of 
organisms, but does enhance host defense as it is necessary for the optimal survival of infected mice. 
Key  words:  Cryptococcus, Host defense, Lymphocyte subsets, Mice, Mixed Lymphocyte Reaction 
Abbreviat ions:  3H-TdR - 3H-thmidine; CFU - colony forming units; FITC - Fluorescein isothiocyanate; 
MLR - mixed lymphocyte reaction; PBS - phosphate buffered saline 
Introduct ion 
Cryptococcus neoformans is a worldwide patho- 
gen that predominantly infects patients with de- 
fects in cell mediated immunity, especially those 
with the acquired immune deficiency syndrome 
(AIDS) [1-3]. C. neoformans is believed to be 
acquired by inhalation, in most cases without 
leading to symptomatic infection [4]. In some 
cases, however, C. neoformans induces a variety 
of pulmonary infections [5-7]. Additionally, the 
organism may induce lethal meningitis, fre- 
quently in patients without demonstrable lung in- 
fection [8]. These findings suggest that both pul- 
monary and systemic host defenses are essential 
to prevent cryptococcal infections. These defense 
mechanisms, complex and currently incompletely 
understood [9], must be better defined to permit 
development of immunomodulatory therapies or 
vaccines. 
Experimental models of cryptococcal infection 
clearly indicate the importance T cell function for 
optimal host defense. CD4 positive T cells protect 
mice infected with minimally virulent [10, 11] and 
highly virulent isolates of C. neoformans [12]. By 
contrast, CD8 positive T cells are heterogeneous 
in function and could either impair host defense 
to C. neoformans by acting as suppressor cells 
[13, 14] or enhance defenses by lysing infected 
macrophages or by secreting activating cytokines 
such as IFN-7 [15, 16]. To determine the net ef- 
fect of CD8 positive T cells in host defenses it is 
necessary to examine their function using in vivo 
model systems. In this regard a particularly useful 
approach is ablation of specific cell types by mon- 
oclonal antibody treatment. Using this approach, 
it has recently been shown that CD8 positive T 
cells are crucial for optimal host defense to infec- 
tion of mice with minimally virulent strains of C. 
neoformans that do not result in a lethal infection 
[10, 11]. However, the role of CD8 positive T 
cells following inoculation with a highly virulent 
isolate of C. neoformans that does cause a lethal 
infection is unknown. Further, it has recently 
been shown that CD8 positive T ceils are crucial 
for optimal host defense to an intrapulmonary 
cryptococcal infection [10, 11]. However, the role 
of CD8 positive T cells following intravenous in- 
oculation, which mimics the stage of intravascular 
dissemination that leads to fatal meningitis, is 
unknown. 
We performed the present experiments to de- 
termine the effect of CD8 T cell depletion during 
a life-threatening infection due to C. neoformans. 
Mice depleted of CD8 positive T cells by mono- 
clonal antibody injections in vivo were challenged 
by the intratracheal route (which mimics natural 
pulmonary infection) or by the intravenous route 
(which mimics disseminated infection). We found 
that depletion of CD8 positive T cells decreased 
survival of mice infected with highly virulent C. 
neoformans by either route, indicating the impor- 
tance of this cell type in both phases of infection. 
Surprisingly, however, depletion of CD8 positive 
T cells did not reduce the organism burden in the 
lungs or other organs. 
Methods 
Mice. Specific pathogen-free C57B1/6 (H-2b), 
Balb/c nu/nu, CBA/Ca, (H-2 k) and B6.C-H-2 
bml (mutated H-2K b) mice were obtained from 
Jackson Laboratories (Bar Harbor, ME) or Ban- 
ton Kingman (Fremont, CA). Mice were housed 
in a sterile laminar flow, specific pathogen-free 
environment. Mice were tested routinely for my- 
coplasma, Sendai virus, and mouse hepatitis 
virus. Mice were given mouse chow and water ad 
libitum. 
Antibodies. The hybridoma YTS 169.4 was a 
generous gift of H. Waldmann (University of 
Cambridge, Cambridge, UK) [17, 18]. YTS 169.4 
produces a monoclonal antibody (rat IgG2b) that 
binds to murine CD8. Monoclonal antibodies 
were isolated and purified using previously de- 
scribed methods [12]. Briefly, hybridomas were 
grown as ascites in pristane-treated BALB/c 
nu/nu mice [19]. The monoclonal antibody was 
purified from ascites by protein A column chrom- 
atography (MAPS II, Biorad, Richmond, CA). 
The monoclonal antibody was dialyzed into phos- 
phate buffered saline (PBS) and quantified by 
spectrophotometry (Beckman, Palo Alto, CA) at 
280 nanometers. Monoclonal antibody purity was 
tested by SDS-PAGE. For immunofluorescent 
staining, monoclonal antibody GK1.5 (anti-CD4) 
was generated and purified as previously de- 
scribed [12]. Anti-Thy 1.2 was obtained from 
Becton Dickinson (Mountain View, CA). Fluor- 
escein isothiocyanate (FITC)-conjugated goat 
anti-rat F(ab') 2 was obtained from Jackson Im- 
munoresearch (West Grove, PA). Rat IgG was 
obtained from Cappell (Westehester, PA). 
Preparation of C. neoformans and cryptococcal 
antigen. C. neoformans strain 145 serotype A 
(145A) was a generous gift of Judith Domer (Tul- 
ane University, New Orleans, LA). Strain 145A 
is highly virulent in mice and can induce 100% 
mortality [12]. C. neoformans organisms were 
maintained on Sabouraud's slants (Difco, De- 
troit, MI) and passaged to fresh slants monthly. 
To produce an inoculum, the organisms were 
passed to Sabouraud's broth containing 1% neo- 
peptone and 2% dextrose (Difco) and were 
grown for 48 hours at 35 °C. Significant clumping 
was not observed with this strain. Immediately 
before inoculation, organisms were counted by 
hemocytometer. The count was verified by mak- 
ing serial 10-fold dilution of the inocula, plating 
them on Sabouraud's agar and counting the 
number of colony forming units (CFU) at 48 
hours. Hemocytometer counts were invariably 
log10 = 0.1-0.3 greater than the CFU determined 
by agar spread plates. Inoculum size was ex- 
pressed as logm -+ sem. 
Depletion of CD8 positive T cells in vivo. Anti- 
body was administered to mice by the intraperi- 
toneal route. One hundred p~g of YTS 169.4 or rat 
IgG (control) were placed into 200 p3 of normal 
saline. Treatments were given two days before 
inoculation with C. neoformans (day -2 ) ,  the day 
of inoculation (day 0), two days after inoculation 
(day +2), and weekly thereafter (days + 7, 
+ 14, + 21, etc.). Mice depleted of CD8 positive 
T cells are frequently maintained in our facility 
for greater than 100 days without difficulty. 
Infection of mice with C. neoformans. For intrav- 
enous inoculation, 0.5 ml of normal saline con- 
taining C. neoformans was injected into the lat- 
eral tail vein of unanesthetized mice. 
Intratracheal inoculation was performed as pre- 
viously described [22]. Briefly, mice were anes- 
thetized with pentobarbital (80 mg kg-1), placed 
in the supine position, and the trachea was ex- 
posed. The trachea was intubated with a blunt 
steel needle advanced through the mouth. A plas- 
tic cannula (PE-10 tubing, Clay Adams, Parsip- 
pany, NJ) was passed through the steel needle 
until the tip of the plastic cannula was 2.6 cm 
from the teeth. Five microliters of normal saline 
containing C. neoformans was deposited in the 
trachea by injecting 100 ixl of air. To quantitate 
the size of the delivered inoculum, five mice were 
killed immediately after inoculation and the num- 
bers of CFU deposited in the lungs was deter- 
mined. For this purpose, lungs were removed 
aseptically and were placed in sterile plastic bags 
containing 2 ml sterile water. The bags were next 
mechanically disrupted in a tissue stomacher (Sto- 
macher Lab Blender 80, Tekmar Co., Cincinnati, 
OH). Next, the lung tissue was ground in a 15 ml 
Ten Broeck tissue grinder (Fisher Scientific, Pitts- 
burgh, PA). Serial 10-fold dilutions were made 
and the numbers of CFU determined by plating 
on Sabouraud's agar. 
Experimental protocols. After antibody injection, 
infected mice were divided into groups and the 
following experiments were performed. To con- 
firm the adequacy of CD8 depletion, infected 
mice were killed and cells from peripheral blood, 
spleen, peripheral lymph nodes, and lungs were 
analyzed by immunofluorescence staining and 
flow cytometry. To further confirm functional de- 
pletion of CD8 positive T cells, in separate ex- 
periments the spleens of uninfected C57B1/6 mice 
were placed in mixed lymphocyte reactions 
(MLR) and proliferative responses measured. 
These experiments examined the response both 
to fully allogeneic stimulator cells and to stimul- 
ator cells that differ only at a single MHC class I 
locus. To determine the effect of CD8 depletion 
on host defense against C. neoformans, we per- 
formed both survival studies and analysis of or- 
ganism clearance as described below. 
Tissue harvesting for lymphocyte staining and 
MLR generation. Seven days after inoculation, 
C57B1/6 mice were deeply anesthetized and i ml 
of blood withdrawn from the retro-orbital plexus 
was placed into tubes containing heparin (Micro- 
tainer, Becton Dickinson). The mice were killed 
by exsanguination and the spleen, peripheral 
(axillary and inguinal) lymph nodes, and lungs 
were removed. The erythrocytes in the peripheral 
blood sample were lysed by incubation with Tris- 
NH4C1 for 5 minutes at 4 °C; the remaining cells 
were washed three times with Hanks balanced 
salt solution with centrifugation at 400 x g for 10 
minutes between washes. Spleens were passed 
through a 60-mesh stainless steel sieve. The eryth- 
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rocytes were lysed and the remaining cells were 
incubated on a nylon wool column to purify T 
cells [23]. Nylon wool-nonadherent cells were 
eluted from the column and washed as above. 
Lymph nodes were processed in the same manner 
as the spleens but without erythrocyte lysis. 
Lungs were minced with scissors to 1-2 mm size 
and suspended in collagenase 150 units ml -a 
(Sigma, Chemicals, St. Louis, MO) for one hour 
at 37 °C. Next, erythrocytes were lysed and the 
remaining cells purified on a nylon wool column. 
Quantification of T cell subsets. Immunofluoresc- 
ence staining and flow cytometry were performed 
as previously described [12]. Briefly, one million 
cells of each tissue type were incubated with 50 txl 
of either anti-Thy 1.2 (1/10 dilution), anti-CD8 
(YTS 169.4; 5 txg), or anti-CD4 (GK1.5; 5 ~g). 
The secondary staining antibody consisted of 
30 txl of a 1/20 dilution of FITC-labeled F(ab')2 
fragment of goat anti-rat IgG (Jackson Immuno- 
research). Control samples were incubated with 
the secondary antibody alone. Cells were ana- 
lyzed for forward angle and 90 ° light scatter and 
green fluorescence by flow cytometry, using an 
EPIC flowcytometer (Coulter, Hialeah, FL). 
Only cells expressing forward angle and 90 ° light 
scatter characteristics of lymphocytes were ana- 
lyzed. 
Measurement of mixed lymphocyte reaction 
(MLR). Nylon wool non-adherent splenocytes 
prepared as described above from CD8-depleted 
C57Bl/6 mice were used as responder cells in an 
MLR. Responder cells were suspended in round 
bottomed wells of 96 well microtiter plates at 
5 x 10Sm1-1 in complete medium, which con- 
sisted of RPMI 1640 containing 10% fetal bovine 
serum, 2 mM glutamine, 100 units ml 1 penicillin, 
1001xgm1-1 streptomycin, 0.2~gm1-1 ampho- 
tericin B, l mM sodium pyruvate (all from 
GIBCO, Grand Island, NY), 2.5 x 10-SM 2- 
mercaptoethanol (Sigma), and 0.1 mM non-es- 
sential amino acids (Whittaker, Walkerville, 
MD). As stimulator cells, we used irradiated 
(2500 rads) splenocytes from either of two differ- 
ent mouse strains: CBA/Ca mice, which are fully 
allogeneic to C57B1/6 mice and thus differ at both 
MHC class I and class II loci; and B6.C-H-2 bin1 
mice, which are identical to C57B1/6 mice except 
for a 3 amino acid substitution in the gene coding 
for the H2-K molecule [24] and thus differ only 
at a class I locus. Stimulator cells were add to 
quadruplicate miaotiter wells containing C57B1/6 
responder cells at concentrations of 0 (control), 
2.5 x 105 or 5 x 105 cells per well in medium. 
Cultures were incubated in 5% CO2 at 37 °C until 
optimal proliferation was achieved (3 days for 
bml stimulator cells, or for 4 days for CBA/Ca 
stimulator cells), and then were pulse with 1 uCi 
per well 3H-thymidine (3H-TdR). Sixteen hours 
later, cells were harvested and incorporated 
radioactivity was determined as cpm using a 
liquid scintillation counter. 
Survival and clearance studies. Separate groups 
of mice were used for survival and clearance stud- 
ies. For survival studies, groups of 10 to 12 mice 
were infected with C. neoforrnans by either the 
intratracheal or intravenous routes, observed 
until moribund and then anesthetized and killed. 
For cryptococcal clearance studies, five mice from 
both experimental and control groups were killed 
at various times during infection induced by 
either the intratracheal or intravenous routes. 
Lungs, spleen, liver, kidney, and brain were re- 
moved and individually processed in the stom- 
acher and tissue grinder as described above for 
the lung. Cryptococcal CFU in each organ were 
quantified on Sabouraud's agar plates. Sabou- 
raud's agar did not contain antibiotics, and con- 
taminating organisms were seldom detected. 
Statistical analysis. Values are expressed as mean- 
+ SEM. The significance of difference between 
control and experimental groups was calculated 
by the unpaired two-tailed Student's t-test, or 
analysis of variance for multiple comparisons, and 
a significant difference accepted at p < 0.05. 
Results 
Phenotypic and functional evidence of  CD8 deple- 
tion. Flow cytometric analysis confirmed that the 
monoclonal antibody treatment protocol used in 
these experiments markedly reduced numbers of 
CD8 positive T cells from peripheral blood, lym- 
phoid organs and lungs of mice infected with C. 
neoformans. In the blood, CD8 positive lympho- 
cytes were reduced from 24% in control mice 
to 2% in mice that received YTS 169.4. CD8 
lymphocytes were reduced in the lung from 17% 
to 4%, in the spleen from 22% to 5%, and in 
lymph nodes from 31% to 1%. Thus, similar to 
previous reports [11], we confirm that the mono- 
clonal antibody YTS 169.4 depletes CD8 lympho- 
cytes in vivo. Functional evidence of CD8 lym- 
phocyte depletion was obtained from experiments 
evaluating the MLR in CD8 depleted and normal 
animals. Depletion of CD8 T cells selectively 
abolished proliferative responses to MHC class I 
but not class II antigens (Fig. 1). Control C57B1/6 
mice treated with rat IgG mounted a vigorous 
response to stimulator cells from B6.C-H-2 bin1 
mice, from which they differ only at a mutation 
within the H-2Kb locus, a class I difference (Fig. 
1A). Treatment with YTS 169.4 almost totally 
abolished this response. By contrast, treatment 
with YTS 169.4 did not decrease the response of 
C57Bv6 splenocytes to fully allogeneic stimulator 
cells from CBA/Ca mice, from which they also 
differ at MHC class II loci (figure 1B). These 
results indicate complete depletion of alloreactive 
CD8 positive T cells with preservation of alloreac- 
tive CD4 positive T cells. 
Effect of  CD8 cell depletion on survival of  mice 
infected with a highly virulent strain of  C. neofor- 
mans. Depletion of CD8 positive T cells signifi- 
cantly decreased survival of mice infected with 
strain 145A, a highly virulent strain of C. neofor- 
mans. This adverse effect on survival was seen 
both in mice inoculated by the intratracheal route 
(Fig. 2) and in mice inoculated intravenously 
(Fig. 3). In the control mice inoculated by the 
intratracheal route, the first mouse died on day 
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39, the mean survival was 51.3 + 2.4 days, and 
the last mouse died on day 65. By contrast, in 
the CD8-depleted mice inoculated by the intratra- 
cheal route, the first mouse died on day 38, the 
mean survival was 44.2 + 1.3 days (p < 0.02), and 
the last mouse died only 51 days after inoculation. 
In the control mice inoculated by the intravenous 
route, the first mouse died on day 17, the mean 
survival was 26.4 -+ 2.5 days, and the last mouse 
died on day 43. By contrast, in the CD8-depleted 
mice inoculated by the intravenous route, the first 
mouse also died on day 17, but the mean survival 
was 20.3-+ 0.7 days (p <0.04),  and the last 
mouse died only 24 days after inoculation. Taken 
together, these results indicate that CD8 positive 
T cells contribute to optimal host defense during 
both the initial pulmonary phase and the subse- 
quent hematogenous dissemination of cryptococ- 
cal infection. 
Effect of  CD8 depletion on clearance of  C. neofor- 
mans. Clearance studies suggested that the ad- 
verse effect of CD8 depletion in vivo in C57B1/6 
mice inoculated with strain 145A was not due 
simply to a difference in reduction of organism 
burden (Table 1). After inoculation by the intra- 
tracheal route, CD8-depleted C57B1/6 mice had 
the same organism burdens initially, at sixteen 
days (data not shown), and at 28 days as control 
C57Bll6 mice injected with rat IgG (Table 1). 
Similar results were seen in C57B1/6 mice inocu- 
lated by the intravenous route and assayed at 15 
days (data not shown) and 21 days (Table 1). 
Discussion 
Our results demonstrate that: (1) CD8 positive T 
cells are depleted functionally (abrogation of a 
class I MHC restricted MLR) and phenotypically 
in mice receiving injections of anti-CD8 mono- 
clonal antibody (YTS 169.4), (2) CD8 positive T 
cells are crucial to the survival of mice infected 
with a highly virulent strain of C. neoformans, 
both during initial pulmonary infection and dur- 
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Fig. 1. Effect of CD8 depletion in vivo on the ability of splenocytes to respond in a mixed lymphocyte reactions (MLR). C57B1/6 
mice were treated with 100 izg monoclonal antibody YTS 169.4 or rat IgG on days - 2 ,  0, and +2. Spleens were removed on day 
+7 and 5 x 105 nylon wool-nonadherent cells were placed in each well of 96-well microtiter plates in a final volume of 0.2 ml 
complete medium. As stimulators, splenocytes were irradiated (2500 rads) and added at 2.5 x 105 (cross-hatched bars) or 5 x l0 s 
(black bars) cells per well. Control wells received no stimulator cells (open bars). Cultures were incubated for three days, pulsed 
with i uCi per well 3H-TdR and harvested 16 hours later. A: Stimulator cells from B6.C-H-2 bml mice. B: Stimulator cells from 
fully allogeneic CBA/Ca mice. Wells receiving irradiated stimulator cells of either strain alone incorporated less than 500 cpm. 
Data are mean --- SEM of quadruplicate samples. 
(3) Surprisingly, however, the adverse effect on 
survival could not be explained by an increase in 
organism burden in any organ of CD8-depleted 
mice infected by either route. 
Optimal host defense against C. neoformans 
undoubtedly involves interaction between phago- 
cytes and immunoregulatory lymphocytes 
[9, 12, 16, 25, 26]. The crucial role of T cells in 
defense against C. neoformans has been well es- 
tablished by the markedly increased susceptibility 
to lethal infection of inbred mice with genetic 
deficiencies of T cell function [11, 20, 27-29]. The 
relative contributions of individual T cell sub- 
types, are being assessed using the technique of 
in vivo subset depletion by monoclonal antibody 
treatment. This technique has shown that CD4 
positive T cells are required for optimal protec- 
tion in mice infected with minimally virulent 
(strains 184A, 52D) [10, 11] and highly virulent 
(strain 145A) isolates of C. neoformans [12]. 
Interestingly, in the latter study we found that 
depletion of CD4 cells did not reduce organism 
clearance from the lung. Because this finding sug- 
gested that other lymphocyte subsets were in- 
volved in clearance, we next studied the role of 
CD8 positive T cells. 
Based on their heterogeneous functional capa- 
bilities, CD8 positive T cells could conceivably 
either enhance or reduce host defense to C. neo- 
formans. CD8 positive T cells could enhance host 
defense to C. neoformans indirectly by producing 
cytokines such as IFN-y [30-32], which is capable 
of activating macrophages for anticryptococcal 
activity [16] or directly by functioning as cytotoxic 
cells. In the latter case, CD8 positive T cells could 
themselves impair cryptococcal growth, a capac- 
ity observed in vitro [15]. Additionally, CD8 posi- 
tive T cells may lyse infected macrophages (which 
r -  
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Fig. 2. Effect of CD8 lymphocyte depletion in vivo on survival of C57B1/6 mice infected intratracheally with a highly virulent 
strain of C. neoformans. C57B1/6 mice were treated with 100 Ixg monoclonal antibody YTS 169.4 (heavy line) or rat IgG (light 
line) on days - 2 ,  0, +2, and +7, and weekly thereafter. Mice were infected by the intratracheal route on day 0 with strain 145A 
C. neoformans and the day of death recorded. The inoculum of C. neoformans deposited in the lungs was LOglo = 3.83 -+ 0.02 cfu. 
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Fig. 3. Effect of CD8 lymphocyte depletion on survival of C57B1/6 mice infected intravenously with a highly virulent strain of 
C. neoformans. C57B1/6 mice were treated with 100 ~g monoclonal antibody YTS 169.4 (heavy line) or rat IgG (light line) on 
days - 2 ,  0, +2, and +7, and weekly thereafter. Mice were infected by the intravenous route on day 0 with strain 145A C. 
neoformans and the day of death recorded. The inoculum of C. neoformans injected was LOgl0 = 3.74. 
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Table 1. Effect of CD8 cell depletion on burden of a highly virulent strain of C. neoforrnans in various organs 
Route of inoculation 
Intratracheal Intravenous 
Organ Rat IgG YTS 169.4 Rat IgG YTS 169.4 
Lung 6.57 +- 0.08 6.78 -+ 0.25 NS 3.30 _+ 0.40 4.00 + 0.50 NS 
Spleen 2.80 -+ 0.04 2.64 -+ 0.33 NS 3.92 -+ 0.24 3.60 -+ 0.36 NS 
Liver 3.80 + 0.20 3.62 + 0.24 Ns 4.33 _+ 0.44 4.70 +- 0.36 NS 
Kidney 2.44 +- 0.13 2.59 -+ 0.30 NS 3.76 -+ 0.14 3.92 -+ 0.23 NS 
Brain 4.26 -+ 0.60 4.38 +- 0.44 NS 6.20 -+ 0.21 6.45 _+ 0.42 NS 
Mice were treated with 100 p,g monoclonal antibody YTS 169.4 or rat IgG on days -2,  0, +2, and +7 and weekly thereafter. 
Mice were infected with strain 145A C. neoformans on day 0 by the indicated route. At various times later, mice were killed and 
cryptococcal burden determined by plating serial dilutions of macerated organs on Sabouraud's agar plates. All data are Log10 
cfu as mean -+ SEM of five mice per group. In the mice inoculated intratracheally, the initial inoculum was Log10 = 4.50 +_ 0.30 
cfu and mice were assayed at day 28. In the mice inoculated intravenously, the initial inoculum was Log10 = 2.38 cfu and mice 
were assayed at day 21. NS = not significant (p > 0.05, unpaired Student's t test). 
inefficiently kill ingested organisms of  some C. 
neoformans strains [33, 34]). Such a lytic action, 
which has been  demons t ra ted  in vitro for  mur ine  
macrophages  infected with Leishmania rnexicana 
[35], would  be anticipated to limit t ranslocat ion 
of  viable organisms to o ther  organs [36]. Al ter-  
nately,  CD8 positive T cells funct ion as sup- 
pressor  cells following immunizat ion with soluble 
cryptococcal  ant igen [9, 13]. Our  data  indicate 
that  the net  effect of  CD8 positive T cells during 
infection with strain 145A is to enhance  host  de- 
fense. 
We believe that  it is essential that  strain vari- 
at ion in cryptococcal  virulence be considered in 
investigations of  host  de fenses  against cryptoc-  
occi. Cryptococci  of  different strains have been  
known  for some time to differ in virulence in 
exper imental  mode l  systems. It is possible, but  
current ly unproven ,  that  strain-specific differ- 
ences in virulence explain why serious cryptococ-  
cal infection at t imes occurs in patients who are 
not  obviously immunocompromised .  The  molecu-  
lar basis for strain-specific differences in virul- 
ence is uncertain.  Var ious  strains of  C. neofor- 
rnans exhibit stable differences in capsular  size 
in vitro and this difference has been  found by 
some investigators to correlate  with differences 
in virulence [37, 38]. Cryptococcal  polysacchar-  
ide, the major  capsular  const i tuent ,  blocks phago-  
cytosis of  C. neoformans by macrophages  
[39, 40], inhibits lymphocy te  prol iferat ion in vitro 
[41, 42] and induces p ro found  immunosuppres -  
sion when injected into mice [43]. However ,  o ther  
more  detailed studies have indicated that  capsular 
size alone does not  complete ly  predict  virulence 
[44, 45]. It is likely that  addit ional  virulence fac- 
tors exist. One  such factor  could be  the ability of  
the host  immune  system to recognize the patho-  
gen and respond  by the genera t ion  of  a specific 
immune  response.  
In  the present  experiments ,  it was impor tan t  
to de termine  that  in vivo monoc lona l  an t ibody 
t rea tment  p roduced  a defect  in recognit ion and 
proliferat ion by CD8 positive T cells. For  this 
purpose ,  we evaluated the capaci ty of  CD8-de-  
pleted splenic lymphocytes  to respond  to class I 
disparate cells f rom B6.C-H-2  bin1 mice. Class I 
M H C  molecules  of  B6 .C-H-2  b m l  mice are iden- 
tical to those of  C57B1/6 mice except  for a 3 
amino acid substi tution in the H2-K molecule  
[24]. Exposure  of  CD8 positive T cells f rom 
C57B1/6 mice to b m l  splenocytes have previously 
been  shown to lead to a vigorous M L R  [46]. 
Therefore ,  the observed abrogat ion  of  the re- 
sponse of  B6 to b m l  by in vivo adminis t rat ion of  
YTS 169,4 confirmed functional  deplet ion of  CD8 
positive T cells. The  selectivity of  this in vivo 
deplet ion was confirmed by the observat ion that  
splenocytes from mice treated with YTS 169.4 
proliferated normally to fully allogeneic spleno- 
cytes from CBA/Ca mice. 
The mechanism whereby depletion of CD8 
positive T cells impairs survival of mice infected 
with strain 145A C. neoforrnans is unknown. We 
investigated the possibility that depletion of CD8 
positive T cells decreases organism clearance. 
Previous studies that used minimally virulent 
strains of C. neoformans (strain 52D, strain 
184A) found that depletion of CD8 positive T 
cells resulted in an increased burden of cryptoc- 
occi in lungs, brain, and spleen after intratracheal 
inoculation [10, 11]. While CD8 positive cells play 
an important role in organism's clearance follow- 
ing infection with minimally virulent organisms, 
that mechanism is clearly not applicable in crypto- 
coccal infection of C57Bv6 mice with strain 145A 
C. neoformans by either the intratracheal or the 
intravenous route. Thus, it is apparent that CD8 
positive T cells (and potentially their functional 
subsets) are capable of contributing to crucial an- 
ticryptococcal defense by different mechanisms 
depending on organism virulence. At present the 
mechanisms are elusive since it is not technically 
feasible to selectively deplete mice of only cyto- 
toxic or only cytokine-releasing CD8 positive T 
cells. An alternative approach to this end would 
be to selectively replete T cell deficient nude or 
scid mice with selected T cell clones. 
We found that the number of organisms were 
not altered by CD8 lymphocyte depletion. A pos- 
sibility to explain the current results is that a 
protective DTH response might 'wall of' the or- 
ganism as previously suggested [47]. This might 
localize C. neoformans to small areas with high 
concentrations of organisms and improve survival 
without altering the overall number of organisms 
recoverable from an organ. We have found that 
CD8 cells are important in DTH to C. neofor- 
roans [48]. If this response was partially mediated 
by CD8 positive lymphocytes, then it might ex- 
plain increased survival without decreasing the 
burden of organisms. Alternately, CD8 positive 
T cells might limit the release or effects of a toxic 
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substance produced by C. neoformans that would 
improve survival without altering the burden of 
organisms. Since the mortality of mice is related 
to the cellular infiltration, and resulting cerebral 
edema [49], it is possible that depletion of CD8 
positive T cells suppress the immune response 
that leads to cerebral edema without altering the 
burden of organisms. A final possibility is that 
CD8 positive T cells are crucial for determining 
the balance between Thl and Th2 CD4 positive 
T cell subsets [50]. The balance between these 
two subsets, which differ in cytokine production, 
is crucial to the outcome of several parasitic infec- 
tions [51, 52]. Whether a similar dependence on 
CD4 positive T cell subsets pertains in cryptoc- 
occosis is currently unknown. As mentioned pre- 
viously, CD8 positive T cells can secrete IFN-% 
which has been shown in culture to inhibit induc- 
tion of Th2 CD4 positive T cells [53]. We are 
actively exploring expression of Thl and Th2 CD4 
positive T cell subsets in experimental infection 
of mice with several strains of cryptococci. 
In summary, we have shown that CD8 positive 
T cells are necessary for optimal murine host de- 
fense to a highly virulent strain of C. neoformans. 
These results complement previous observations 
that CD8 positive T cells are also essential for 
optimal defense against less virulent strains of C. 
neoformans [10, 11] (in the latter case at least 
in part by reducing the organism burden). It is 
possible that the beneficial effects of CD8 positive 
T cells could be enhanced even in partially CD4- 
deficient hosts if cryptococcal antigens recognized 
by CD8 positive T cells were used. Thus, stra- 
tegies designed to stimulate this population of 
cells should be explored as immunotherapy 
against this ubiquitous fungal pathogen. 
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